Oncology

Director of Los Angeles-based Cedars-Sinai Cancer, Dan Theodorescu, MD, PhD, is stepping down from the position after serving for six years. 

About 70% of physicians said they were not following the recommended guidelines for the treatment of metastatic prostate cancer, according to a study published Dec. 9 in JAMA Network Open.

New York City-based Memorial Sloan Kettering Cancer Center has partnered with Amazon Web Services to accelerate cancer innovation and research through AI, high-performance computing and cloud technologies. 

Historically, cancer care largely focused on the fight for survival. Now, thanks to advancements in screening and treatment, many patients are living decades beyond their diagnosis. 

A new blood test has been found to detect early stage pancreatic cancer with 85% accuracy when used alongside a carbohydrate antigen 19-9 test, according to a study published Feb. 12 in Science Translational Medicine.

Johnson City, Tenn.-based Ballad Health will expand radiation oncology services at the system's Greeneville (Tenn.) Community Hospital following a $1 million gift from Scott Niswonger.

John Zaia, MD, director of the Center for Gene Therapy at Duarte, Calif.-based City of Hope, died Feb. 11 at age 82.

Leading experts and researchers from Philadelphia-based Fox Chase Cancer Center and Tampa, Fla.-based Moffitt Cancer Center have collaborated on a guideline review for melanoma care. The review was published Nov. 4, 2024, in the Annals of Surgical Oncology.

Thirteen cancer clinics of the Detroit-based Barbara Ann Karmanos Cancer Institute have joined YesRx's cancer drug repository program, expanding patient access to free cancer medications across Michigan. 

Electronic patient-reported outcomes improved clinical outcomes, the patient experience and service utilization among cancer patients, according to a study published Feb. 7 in Nature Medicine.